Business · 1 sources covering this

Dr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer

It is the second approved indication in India and expands use of the Shanghai Junshi Biosciences’ drug beyond the initially approved indication in nasopharyngeal carcinoma

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

The HinduLean L·1h ago
Dr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer
It is the second approved indication in India and expands use of the Shanghai Junshi Biosciences’ drug beyond the initially approved indication in nasopharyngeal carcinoma
Read at The Hindu →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/9090c408d36df78bb4482ecdf6ea5999e2fa7ec7"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Dr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer"></iframe>

Dr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer

How 1 sources are covering this

Dr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer

More from Business

SBI probes dark web exposure of nearly 3,900 customer records

Form 173A notified to claim exemption on G-Sec gains

Amitabh planned to be taxi driver if acting failed

Delhi HC to urgently hear pleas by CJP's Das, Ranka, AISA's Neha Bora

Reader

Trust & legal

Across the network